Hansen Gwenn
Chief Scientific Officer
Hansen Gwenn has filed 11 SEC Form 4 filings (35 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Nov 3, 2026.
On the most recent filing, Hansen Gwenn is listed as Chief Scientific Officer at Nurix Therapeutics, Inc. Inside the rolling window, Hansen Gwenn reported no open-market purchases and 10 open-market sales totaling $758K in NRIX. The largest disclosed transaction in the window is a sale of 4,356 NRIX shares on Aug 5, 2026, worth $109K.
Companies traded
Other insiders at NRIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$758K
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| NRIX | Chief Scientific Officer | Sale | 3,957 | $104K | Nov 3 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 1,452 | $39K | Nov 3 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 1,452 | $36K | Oct 15 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 1,452 | $37K | Sep 1 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 4,356 | $109K | Aug 5 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 4,111 | $100K | Aug 5 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 3,847 | $90K | Jul 30 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 5,394 | $108K | Jun 25 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 3,214 | $53K | Apr 30 | SEC ↗ | |
| NRIX | Chief Scientific Officer | Sale | 4,895 | $81K | Jan 30 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 30, 2025 | NRIX | Sale | $52K |
Frequently asked questions
How many SEC Form 4 filings has Hansen Gwenn made?
Hansen Gwenn has filed 11 SEC Form 4 filings (35 transaction rows) across 1 company since 2025.
Which companies does Hansen Gwenn trade?
Hansen Gwenn has filed SEC Form 4 disclosures for 1 company, including NRIX.
When was Hansen Gwenn's most recent SEC Form 4 filing?
Hansen Gwenn's most recent SEC Form 4 filing on Tracefour is dated Nov 3, 2026.
What is Hansen Gwenn's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hansen Gwenn is listed as Chief Scientific Officer.
What is Hansen Gwenn's total buy and sell value in the current window?
Inside the rolling retention window, Hansen Gwenn bought $0 and sold $758K based on SEC Form 4 filings.
What was Hansen Gwenn's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,356 NRIX shares on 2026-08-05, worth $109K, per SEC Form 4 filings.